The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Cabergoline 1 mg Tablets

Renata Pharmaceuticals (Ireland) LimitedPA22865/011/001

Main Information

Trade NameCabergoline 1 mg Tablets
Active SubstancesCabergoline
Dosage FormTablet
Licence HolderRenata Pharmaceuticals (Ireland) Limited
Licence NumberPA22865/011/001

Group Information

ATC CodeN04BC06 cabergoline


License statusAuthorised
Licence Issued13/10/2023
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back